Effectiveness of COVID-19 Vaccination on Transmission: A Systematic Review

Author:

Oordt-Speets Anouk1,Spinardi Julia2,Mendoza Carlos3,Yang Jingyan4ORCID,Morales Graciela5,McLaughlin John M.6,Kyaw Moe H.6ORCID

Affiliation:

1. Epi-C (Epidemiology-Consultancy), 3846 AG Harderwijk, The Netherlands

2. Vaccine Medical Affairs, Emerging Markets, Pfizer Inc., Itapevi 06696-270, Brazil

3. Patient Health and Impact, Pfizer Inc., Mexico City 05120, Mexico

4. Global Value and Access, Pfizer Inc., New York, NY 10017, USA

5. Vaccine Medical Affairs, Emerging Markets, Pfizer Inc., New York, NY 10017, USA

6. Vaccine Scientific Affairs, Pfizer Inc., New York, NY 10017, USA

Abstract

Vaccination against infectious disease affords direct protection from vaccine-induced immunity and additional indirect protection for unvaccinated persons. A systematic review was conducted to estimate the indirect effect of COVID-19 vaccination. From PubMed and Embase, 31 studies were included describing the impact of original wild-type COVID-19 vaccines on disease transmission or viral load. Overall, study results showed the effectiveness of COVID-19 vaccination against SARS-CoV-2 transmission (range 16–95%), regardless of vaccine type or number of doses. The effect was apparent, but less pronounced against omicron (range 24–95% for pre-omicron variants versus 16–31% for omicron). Results from viral load studies were supportive, showing SARS-CoV-2 infections in vaccinated individuals had higher Ct values, suggesting lower viral load, compared to infections among the unvaccinated. Based on these findings, well-timed vaccination programs may help reduce SARS-CoV-2 transmission—even in the omicron era. Whether better-matched vaccines can improve effectiveness against transmission in the omicron era needs further study.

Funder

Pfizer Inc.

Publisher

MDPI AG

Subject

General Medicine

Reference57 articles.

1. World Health Organization (2023, March 31). Timeline: WHO’s COVID-19 Response. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#.

2. World Health Organization (2023, September 18). WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/.

3. The Association of Intensity and Duration of Non-Pharmacological Interventions and Implementation of Vaccination with COVID-19 Infection, Death, and Excess Mortality: Natural Experiment in 22 European Countries;Zhou;J. Infect. Public Health,2022

4. Effectiveness Assessment of Non-Pharmaceutical Interventions: Lessons Learned from the COVID-19 Pandemic;Lison;Lancet Public Health,2023

5. Iezadi, S., Gholipour, K., Azami-Aghdash, S., Ghiasi, A., Rezapour, A., Pourasghari, H., and Pashazadeh, F. (2021). Effectiveness of Non-Pharmaceutical Public Health Interventions against COVID-19: A Systematic Review and Meta-Analysis. PLoS ONE, 16.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3